Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-12-31
Original SEC Filing: Click here

---

Webplus: SVA/20191231/6-K/2_EX-99.1/000.htm SEC Original: tm1928301d1_ex99-1.htm
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children BEIJING, December 27, 2019–Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA) has approved and issued a Product license for the Company’s varicella vaccine to prevent the varicella-zoster virus

---

---

Webplus: SVA/20191231/6-K/1/000.htm SEC Original: tm1928301d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-12-31CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200